Application 012249

Type
NDA
Sponsor
VALEANT PHARM INTL

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001LIBRIUMCHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORAL10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
002LIBRIUMCHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORAL5MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo
003LIBRIUMCHLORDIAZEPOXIDE HYDROCHLORIDECAPSULE;ORAL25MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**YesNo

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
46583SUPPL2016-12-29
46452SUPPL2016-12-21
46311SUPPL2016-12-20